Orion Oyj (ADR)
General ticker "ORINY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $18.2B (TTM average)
Orion Oyj (ADR) follows the US Stock Market performance with the rate: 29.2%.
Estimated limits based on current volatility of 1.1%: low 34.73$, high 35.52$
Factors to consider:
- Company pays dividends (annually): last record date 2025-10-16, amount 0.17$ (Y0.49%)
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [17.64$, 27.28$]
- 2025-12-31 to 2026-12-31 estimated range: [19.04$, 29.11$]
Financial Metrics affecting the ORINY estimates:
- Positive: with PPE of 17.6 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 27.01 > 18.64
- Negative: 0.01 < Interest expense per share per price, % of 0.13
- Positive: 5.52 < Industry operating cash flow per share per price (median), % of 8.11
- Positive: Industry earnings per price (median), % of 5.67 > 4.43
- Positive: Industry inventory ratio change (median), % of -0.66 <= -0.15
- Positive: Return on assets ratio (scaled to [-100,100]) of 20.23 > 6.04
- Negative: Investing cash flow per share per price, % of -1.44 <= -0.66
Short-term ORINY quotes
Long-term ORINY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €1,340.70MM | €1,189.70MM | €1,542.40MM |
| Operating Expenses | €901.10MM | €914.80MM | €1,125.80MM |
| Operating Income | €439.60MM | €274.90MM | €416.60MM |
| Non-Operating Income | €0.70MM | €-3.00MM | €-3.50MM |
| Interest Expense | €1.50MM | €5.20MM | €7.60MM |
| R&D Expense | €135.80MM | €126.90MM | €179.60MM |
| Income(Loss) | €440.30MM | €271.90MM | €413.10MM |
| Taxes | €0.00MM | €55.10MM | €0.00MM |
| Profit(Loss)* | €349.50MM | €216.80MM | €329.90MM |
| Stockholders Equity | €908.10MM | €890.10MM | €1,005.00MM |
| Inventory | €315.60MM | €362.20MM | €418.60MM |
| Assets | €1,503.60MM | €1,438.60MM | €1,629.10MM |
| Operating Cash Flow | €434.40MM | €119.00MM | €293.40MM |
| Capital expenditure | €73.10MM | €116.80MM | €86.90MM |
| Investing Cash Flow | €-154.30MM | €-108.40MM | €-85.20MM |
| Financing Cash Flow | €-159.80MM | €-243.20MM | €-108.80MM |
| Earnings Per Share** | €1.24 | €0.77 | €1.17 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.